Experts spotlight the prostate and bladder cancer presentations they're most excited to see at the 2026 ESMO Congress.
Commentary|Articles|December 5, 2025
Experts Prepare for Several Key MCL Presentations at ASH 2025
Author(s)Caroline Seymour
Fact checked by: Chris Ryan
Hematology experts share the MCL abstracts they’re most looking forward to seeing at the 2025 ASH Annual Meeting.
Advertisement
Advertisement
Research breakthroughs in metabolic reprogramming–driven resistance and next-generation targeted inhibition in mantle cell lymphoma (MCL) are poised to take center stage at the
Related to this article
Read on to see which data are poised to shape clinical discussions and decision-making in lung cancer at the 2026 ESMO Congress in Madrid, Spain.
Experts in gynecologic oncology overview top research being presented at the 2026 ESMO Congress.
First-line IO-based combination regimens were increasingly used and associated with longer observed survival in advanced renal cell carcinoma.
Readers share their opinions on some of the most talked-about breast cancer abstracts they’re looking forward to seeing at ESMO 2026.
Experts spotlight the gastrointestinal cancer presentations they’re most excited to see at the 2026 ESMO Congress.
Experts break down key lung cancer data and trends from the IASLC 2026 World Conference on Lung Cancer.
Experts break down key multiple myeloma data and trends from the 23rd Annual IMS Meeting.
Advertisement
Advertisement